B Group, Inc.
Source: SEC Form 13F · as of Mar 2026B Group, Inc. holds 9 biotech & pharma companies tracked by BioSniper, totaling $65.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$65.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for ADMA BIOLOGICS, INC. (ADMA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ADMAADMA BIOLOGICS, INC. | 3,207,542 | $28.9M |
| CLLSCellectis S.A. | 3,281,501 | $10.4M |
| GPCRStructure Therapeutics Inc. | 127,500 | $6.1M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 1,500,000 | $5.3M |
| SYRESpyre Therapeutics, Inc. | 100,000 | $5.0M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 175,706 | $4.9M |
| ORKAOruka Therapeutics, Inc. | 75,000 | $3.7M |
| APGEApogee Therapeutics, Inc. | 7,500 | $631K |
| SLNOSOLENO THERAPEUTICS INC | 7,500 | $251K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.